No migration of acetabular cups after prophylaxis for heterotopic ossification

Clinical Orthopaedics and Related Research

Volumn 461, Issue , 2007, Pages 125-129

  Ince, Akif ^a,c   Sauer, Ulf ^a   Wollmerstedt, Nicole ^a   Hendrich, Christian ^b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b Orthopädisches Krankenhaus   (Germany)

^c NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRONE; INDOMETACIN; OPIATE; PARACETAMOL; NONSTEROID ANTIINFLAMMATORY AGENT;

ACETABULUM; ADULT; AGED; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HETEROTOPIC OSSIFICATION; HIP PROSTHESIS; HIP RADIOGRAPHY; HUMAN; IRRADIATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS LOOSENING; REOPERATION; ARTICLE; FOREIGN BODY; HIP; HIP OSTEOARTHRITIS; MIDDLE AGED; RADIATION EXPOSURE;

ACETABULUM; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; FOREIGN-BODY MIGRATION; HIP JOINT; HUMANS; INDOMETHACIN; MALE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; OSTEOARTHRITIS, HIP; PROSPECTIVE STUDIES;

EID: 34548337315     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/BLO.0b013e31805c0d82     Document Type: Conference Paper

References (33)

1. Allen HL, Wase A, Bear WT. Indomethacin and aspirin: effect of nonsteroidal anti-inflammatory agents on the rate of fracture repair in the rat. Acta Orthop Scand. 1980;51:595-600.
2. Ayers DC, Evarts CM, Parkinson JR. The prevention of heterotopic ossification in high-risk patients by low-dose radiation therapy after total hip arthroplasty. J Bone Joint Surg Am. 1986;68:1423-1430.
3. Barthel T, Baumann B, Noth U, Eulert J. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam. Acta Orthop Scand. 2002;73:611-614.
4. Bauer R, Kerschbaumer F, Poisel S, Oberthaler W. The transgluteal approach to the hip joint. Arch Orthop Trauma Surg. 1979;95:47-49.
5. Biedermann R, Krismer M, Stockl B, Mayrhofer P, Ornstein E, Franzen H. Accuracy of EBRA-FCA in the measurement of migration of femoral components of total hip replacement: Einzel-Bild-Röntgen-Analyse-femoral component analysis. J Bone Joint Surg Br. 1999;81:266-272.
6. Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr. Ectopic ossification following total hip replacement: incidence and a method of classification. J Bone Joint Surg Am. 1973;55:1629-1632.
7. Cook SD, Barrack RL, Dalton JE, Thomas KA, Brown TD. Effects of indomethacin on biologic fixation of porous-coated titanium implants. J Arthroplasty. 1995;10:351-358.
8. Coventry MB, Scanlon PW. The use of radiation to discourage ectopic bone: a nine-year study in surgery about the hip. J Bone Joint Surg Am. 1981;63:201-208.
9. Ducheyne P, Radin S, King L. The effect of calcium phosphate ceramic composition and structure on in vitro behavior. I. Dissolution. J Biomed Mater Res. 1993;27:25-34.
10. Ehrhart NP, Eurell JA, Constable PD, Gaddy D, Nicholas RW. The effect of host tissue irradiation on large-segment allograft incorporation. Clin Orthop Relat Res. 2005;435:43-51.
11. Engh CA, Massin P, Suthers KE. Roentgenographic assessment of the biologic fixation of porous-surfaced femoral components. Clin Orthop Relat Res. 1990;257:107-128.
12. Frayssinet P, Hardy D, Conte P, Delince P, Guilhem A, Bonel G. Histological analysis of the bone/prosthesis interface in man after implantation of a hip prosthesis coated with plasma-sprayed hydroxyapatite [in French]. Rev Chir Orthop Reparatrice Appar Mot. 1993;79:177-184.
13. Gebuhr P, Sletgard J, Dalsgard J, Soelberg M, Keisu K, Hanninen A, Crawford M. Heterotopic ossification after hip arthroplasty: a randomized double-blind multicenter study tenoxicam in 147 hips. Acta Orthop Scand. 1996;67:29-32.
14. Gebuhr P, Wilbek H, Soelberg M. Naproxen for 8 days can prevent heterotopic ossification after hip arthroplasty. Clin Orthop Relat Res. 1995;314:166-169.
15. Hawkey C, Kahan A, Steinbruck K, Alegre C, Baumelou E, Begaud B, Dequeker J, Isomaki H, Littlejohn G, Mau J, Papazoglou S. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. Br J Rheumatol. 1998;37:937-945.
16. Keller J, Bunger C, Andreassen TT, Bak B, Lucht U. Bone repair inhibited by indomethacin: effects on bone metabolism and strength of rabbit osteotomies. Acta Orthop Scand. 1987;58:379-383.
17. Keller JC, Trancik TM, Young FA, St Mary E. Effects of indomethacin on bone ingrowth. J Orthop Res. 1989;7:28-34.
18. Kjaersgaard-Andersen P, Schmidt SA, Pedersen NW, Kristensen SS, Pedersen P. Early radiolucencies following cemented total hip replacement: influence of postoperative treatment with indomethacin. Orthopedics. 1989;12:401-406.
19. Knabe C, Berger G, Gildenhaar R, Klar F, Zreiqat H. The modulation of osteogenesis in vitro by calcium titanium phosphate coatings. Biomaterials. 2004;25:4911-4919.
20. Knabe C, Ostapowicz W, Radlanski RJ, Gildenhaar R, Berger G, Fitzner R, Gross U. In vitro investigation of novel calcium phosphates using osteogenic cultures. J Mater Sci Mater Med. 1998;9:337-345.
21. Knabe C, Stiller M, Berger G, Reif D, Gildenhaar R, Howlett CR, Zreiqat H. The effect of bioactive glass ceramics on the expression of bone-related genes and proteins in vitro. Clin Oral Implants Res. 2005;16:119-127.
22. Knelles D, Barthel T, Karrer A, Kraus U, Eulert J, Kolbl O. Prevention of heterotopic ossification after total hip replacement: a prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation. J Bone Joint Surg Br. 1997;79:596-602.
23. Krismer M, Biedermann R, Stockl B, Fischer M, Bauer R, Haid C. The prediction of failure of the stem in THR by measurement of early migration using EBRA-FCA: Einzel-Bild-Roentgen-Analyse-femoral component analysis. J Bone Joint Surg Br. 1999;81:273-280.
24. Lieberman IH, Moran E, Hastings DE, Bogoch ER. Heterotopic ossification after primary cemented and noncemented total hip arthroplasty in patients with osteoarthritis and rheumatoid arthritis. Can J Surg. 1994;37:135-139.
25. McMahon JS, Waddell JP, Morton J. Effect of short-course indomethacin on heterotopic bone formation after uncemented total hip arthroplasty. J Arthroplasty. 1991;6:259-264.
26. Persson PE, Sodemann B, Nilsson OS. Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty: a randomized double-blind prospective study of treatment time. Acta Orthop Scand. 1998;69:111-115.
27. Ritter MA, Sieber JM. Prophylactic indomethacin for the prevention of heterotopic bone formation following total hip arthroplasty. Clin Orthop Relat Res. 1985;196:217-225.
28. Rosendahl S, Christoffersen JK, Norgaard M. Para-articular ossification following hip replacement: 70 arthroplasties ad modum Moore using McFarland's approach. Acta Orthop Scand. 1977;48:400-404.
29. Sell S, Willms R, Jany R, Esenwein S, Gaissmaier C, Martini F, Bruhn G, Burkhardsmaier F, Bamberg M, Kusswetter W. The suppression of heterotopic ossifications: radiation versus NSAID therapy: a prospective study. J Arthroplasty. 1998;13:854-859.
30. Solheim E, Pinholt EM, Bang G, Sudmann E. Inhibition of heterotopic osteogenesis in rats by a new bioerodible system for local delivery of indomethacin. J Bone Joint Surg Am. 1992;74:705-712.
31. Tozun R, Pinar H, Yesiller E, Hamzaoglu A. Indomethacin for prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty. 1992;7:57-61.
32. Trnka HJ, Zenz P, Zembsch A, Easley M, Ritschl P, Salzer M. Stable bony integration with and without short-term indomethacin prophylaxis: a 5-year follow-up. Arch Orthop Trauma Surg. 1999;119:456-460.
33. Wurnig C, Schwameis E, Bitzan P, Kainberger F. Six-year results of a cementless stem with prophylaxis against heterotopic bone. Clin Orthop Relat Res. 1999;361:150-158.